$300M Series D funding secured & Dr. Omar Ishrak appointed Biofourmis Chairman Learn More
Chugai is objectively assessing pain associated with endometriosis to better understand its pathology and treatment.
The University of Hong Kong is utilizing the Biovitals Index to remotely monitor and identify COVID-19-related physiological biomarkers that indicate deterioration in patients.
Our digital medicine portfolio consists of products that cover multiple medicine areas, including heart failure, acute coronary syndrome, COPD, oncology, and chronic pain.
The evolution of healthcare technology and personalized AI-based technologies are revolutionizing the way we approach medicine. Learn more about how you can accelerate innovation with digital medicine to improve patient outcomes. Download this reference guide to initiate your virtual care program to realize improved outcomes and efficiencies